Medical image-based tumor microenvironment state analysis method, system and device
By combining tumor pathology images and gene expression data, a weakly supervised learning framework model for predicting immune resistance mechanisms was constructed. This solved the problems of accuracy and cost in predicting immune resistance mechanisms in tumor treatment in existing technologies, and achieved efficient and accurate analysis of immune resistance mechanisms.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NAT HEALTH COMMISSION INST OF SCI & TECH
- Filing Date
- 2026-01-30
- Publication Date
- 2026-06-19
AI Technical Summary
Existing technologies struggle to accurately predict immune resistance mechanisms in cancer treatment, especially in immune checkpoint inhibitor therapy. Traditional methods rely on expensive and hard-to-obtain transcriptome data, which cannot distinguish between different resistance mechanisms, and the results are disconnected from pathological morphology.
By processing tumor pathological tissue images and combining them with gene expression data, a weakly supervised learning framework model for predicting immune drug resistance mechanisms is constructed. Pathologically related gene sequences are used as labels to extract semantic features from image patches. The number of model layers is dynamically set to generate a feature representation of immune drug resistance mechanisms.
It achieves efficient and accurate prediction of the immune drug resistance mechanism in biological individuals, reduces detection costs, is applicable to multi-center and multi-device datasets, and improves the accuracy and generalization ability of prediction.
Smart Images

Figure 1 
Figure 2